NFL LONG Prospective Study
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Feb 6, 2020
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
There is growing concern that repetitive concussions, or even exposure to sub-concussive blows during collision sports, may be associated with chronic neurologic problems, including CTE. Despite the lay media attributing devastating clinical problems to CTE, no studies conclusively demonstrate a connection between the pathological findings and clinical effects. Experts at the 5th International Conference on Concussion concluded that "a cause-and-effect relationship has not yet been demonstrated between CTE and SRCs \[sport-related concussions\]" and "the notion that repeated concussion or s...
Gender
MALE
Eligibility criteria
- Inclusion Criteria for Former NFL Player Group:
- • At least 1 year of participation in National Football League (NFL groups)
- • Retired from professional football
- • Ages between 50-70
- Inclusion Criteria for Healthy Controls:
- • No prior exposure to football, collision sports, or prior concussions
- • They will be matched to former NFL players by age and estimated premorbid intellectual functioning.
- • Ages between 50-70
- Exclusion Criteria:
- • Any contraindications to MRI, PET, or biological study procedures
- • History of Moderate or Severe TBI
- • Current primary Axis I diagnosis of Psychotic Disorder
- • History or clinical suspicion of other conditions (e.g., epilepsy, stroke, dementia) known to cause cognitive dysfunction
- • Diagnosis /associated treatment that would preclude participation in full study protocol (e.g., terminal cancer)
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milwaukee, Wisconsin, United States
Chapel Hill, North Carolina, United States
Milwaukee, Wisconsin, United States
Waltham, Massachusetts, United States
Patients applied
Trial Officials
William Meehan, MD
Principal Investigator
Boston Children's Hospital
Michael McCrea, PhD
Principal Investigator
Medical College of Wisconsin
Jason Mihalik, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials